Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Brémond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Léoné M, Chauvin F, Easton DF, Lenoir GM, Lasset C. Bonadona V, et al. Among authors: mathevet p. Genes Chromosomes Cancer. 2005 Aug;43(4):404-13. doi: 10.1002/gcc.20199. Genes Chromosomes Cancer. 2005. PMID: 15887246
Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.
Bonadona V, Dussart-Moser S, Voirin N, Sinilnikova OM, Mignotte H, Mathevet P, Brémond A, Treilleux I, Martin A, Romestaing P, Raudrant D, Rudigoz RC, Lenoir GM, Lasset C. Bonadona V, et al. Among authors: mathevet p. Breast Cancer Res Treat. 2007 Jan;101(2):233-45. doi: 10.1007/s10549-006-9288-7. Epub 2006 Oct 24. Breast Cancer Res Treat. 2007. PMID: 17061047
Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.
Morice P, Rouanet P, Rey A, Romestaing P, Houvenaeghel G, Boulanger JC, Leveque J, Cowen D, Mathevet P, Malhaire JP, Magnin G, Fondrinier E, Berille J, Haie-Meder C. Morice P, et al. Among authors: mathevet p. Oncologist. 2012;17(1):64-71. doi: 10.1634/theoncologist.2011-0276. Epub 2012 Jan 10. Oncologist. 2012. PMID: 22234626 Free PMC article. Clinical Trial.
Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer: A post-hoc analysis of SENTICOL I and SENTICOL II cohorts.
Balaya V, Guani B, Morice P, Querleu D, Fourchotte V, Leblanc E, Daraï E, Baron M, Marret H, Levêque J, Magaud L, Mathevet P, Lécuru F; SENTICOL Group. Balaya V, et al. Among authors: mathevet p. Gynecol Oncol. 2022 Jan;164(1):53-61. doi: 10.1016/j.ygyno.2021.10.074. Epub 2021 Oct 23. Gynecol Oncol. 2022. PMID: 34696894 Free article.
[Application in France of the 2021 European recommendations on endometrial cancer].
Deluche E, Marti C, Jochum F, Bendifallah S, Azaïs H, Deidier J, Cockenpot V, Menoux I, Kissel M, Balaya V, Betrian S, Mathevet P, Chargari C, Gouy S, Genestie C, Uzan C, Devouassoux-Shisheboran M, Guyon F, Akladios C, Body N, Guani B; groupe SFOG et SFOG campus. Deluche E, et al. Among authors: mathevet p. Bull Cancer. 2023 Jan;110(1):55-68. doi: 10.1016/j.bulcan.2022.11.003. Epub 2022 Nov 30. Bull Cancer. 2023. PMID: 36462971 Review. French.
198 results